Business StandardANAVEX® Life Sciences Corp.Jul 31, 20151 min readNew drug may boost brain power in Alzheimer’s patientsClick here to read article
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
